Home Tags EXEL

Tag: EXEL

Exelixis (EXEL) Stock: Gaining On EU Regulatory Approval

Exelixis, Inc. (NASDAQ: EXEL) investors are cheering this morning as the stock is headed for the top. The gains are ultimately the result of...

Exelixis (EXEL) Stock: Climbing On Earnings

After releasing its earnings early this morning, Exelixis, Inc. (NASDAQ: EXEL) is making a run for the top in the market this morning, The...

Exelixis (EXEL) Stock: Climbing On CABOMETYX® News

Exelixis, Inc. (NASDAQ: EXEL) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that...

Exelixis (EXEL) Stock: Gaining On Completed Submission Of sNDA

Exelixis, Inc. (NASDAQ: EXEL) is off to a strong start in the pre-market hours this morning after announcing that it has completed the submission...

Exelixis (EXEL) Stock: Here’s Why It’s Taking A Dive

Exelixis, Inc. (NASDAQ: EXEL) Exelixis is having an incredibly rough day in the market today. As soon as the opening bell rang, the stock started...

Exelixis (EXEL) Stock: Soaring In The Morning | Doomed In The...

Exelixis, Inc. (NASDAQ: EXEL) Exelixis is having an incredibly strong day in the market today after reporting positive news from a key Phase 2 clinical...

Exelixis (EXEL) Stock Soars On Positive Trial Results

Exelixis, Inc. (NASDAQ: EXEL) Exelixis is having an incredibly strong day in the market today, and for good reason. The company announced incredibly positive trial...

Exelixis (EXEL) Stock Climbs On Solid Study Data

Exelixis, Inc. (NASDAQ: EXEL) Exelixis is having an incredible day in the market today, and for good reason. The company announced data from a pivotal...

Exelixis (EXEL) Stock Continues To Climb On FDA News

Exelixis, Inc. (NASDAQ: EXEL) Exelixis is having an incredible time in the market at the moment, and for a good reason. The company recently received...

Exelixis (EXEL) Stock: Climbing On Exclusive Licensing Agreement!

Exelixis, Inc. (NASDAQ: EXEL) Exelixis is having an incredible day in the market today, and for good reason. The company announced that it has reached...

Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib

We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies...

Reviews

TradeMiner Review: Is It Worth Your While?

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...